One of the promised benefits of 'personalised' medicine is that it will have a positive impact on disease screening and prevention, by enabling more person-specific estimates of risk, and hence more personalised strategies for screening and risk reduction. This article summarises some of the areas in which these approaches are already being implemented, but also outlines some of the potential difficulties and limitations - and challenges the assumption that 'personalised' approaches are necessarily superior for prevention and screening.

Original publication

DOI

10.1080/20502877.2017.1314884

Type

Journal article

Journal

The New bioethics : a multidisciplinary journal of biotechnology and the body

Publication Date

04/04/2017

Volume

23

Pages

21 - 29

Addresses

b The Royal Free Hospital , London , UK.